Brean Murray Raises PT on Onyx Pharma (ONXX); FDA Grants Regorafenib Priority Review; Takeout Speculation Looms

Go back to Brean Murray Raises PT on Onyx Pharma (ONXX); FDA Grants Regorafenib Priority Review; Takeout Speculation Looms